Author: Mr Oliver Eaton BSc (Hons), PG.Cert – Orthopaedic Specialist
Reviewed by: Mr William Sharples BSc (Hons) – Pain Management Expert
Last Updated: September 2025
In this article, you will learn everything you need about knee pain caused by cartilage defects and the most effective treatments, including Autologous Chondrocyte Implantation and an advanced treatment called Prolotherapy.
Knee pain from cartilage damage can be life-limiting, especially for active adults and athletes. When conservative treatments fail, advanced regenerative procedures like autologous chondrocyte implantation (ACI) offer hope for long-term relief and joint preservation. This article explains what ACI is, who it helps, what to expect, and how Prolotherapy at ProHealth Clinic can support your recovery and knee health. ACI is recognized for its clinical excellence, supported by rigorous research and expert involvement.
Introduction to ACI
Autologous Chondrocyte Implantation (ACI) is an advanced surgical procedure specifically designed to address articular cartilage defects within the knee joint. This innovative approach uses a patient’s own healthy cartilage cells—known as chondrocytes—to repair areas of damaged cartilage. The ACI procedure is performed in two stages: first, a small sample of healthy cartilage is harvested from a non-weight-bearing region of the knee. These healthy cartilage cells are then cultured and multiplied in a laboratory over several weeks. In the second procedure, the newly cultured chondrocytes are carefully implanted into the damaged area of the cartilage. By using the patient’s own cells, ACI aims to regenerate new, healthy cartilage, reduce pain, and restore normal joint function. This technique is particularly effective for young patients with isolated cartilage defects, offering a promising solution for those seeking to maintain an active lifestyle and avoid more invasive surgeries.
Causes and Symptoms of Knee Cartilage Damage
Knee cartilage damage can result from a range of causes, including acute injury, previous surgery, or the gradual wear and tear associated with osteoarthritis. Patients may experience persistent pain, swelling, and a limited range of motion in the affected knee. In some cases, damage to the cartilage can also lead to stiffness or even locking of the joint, making everyday activities and sports more challenging. The National Institute for Health and Care Excellence (NICE) has established clear criteria for the treatment of knee cartilage damage, ensuring that only eligible patients are considered for advanced procedures like ACI. According to these guidelines, patients who are suitable for ACI typically have a single, well-defined cartilage defect larger than 2 square centimeters, and have not responded to conservative treatments. Careful review of each case is essential to determine eligibility and to ensure the most effective use of this procedure.
What is Autologous Chondrocyte Implantation (ACI)?
Autologous chondrocyte implantation (ACI) is a cutting-edge surgical procedure designed to repair focal cartilage defects in the knee. It involves harvesting a small sample of the patient’s own healthy cartilage cells (chondrocytes), developing these cells in culture by growing and maturing them in a laboratory, and then implanting them back into the damaged area of the patient’s knee. The goal is to regenerate new, healthy cartilage and restore joint function (NHS, 2023).
ACI is most often recommended for younger, active patients with isolated cartilage injuries who have not responded to physiotherapy, injections, or other conservative treatments. It is not suitable for widespread arthritis or advanced joint degeneration.
Who is a Candidate for ACI?
- Adults (typically under 50) with persistent knee pain from a focal cartilage defect
- Patients with a single, well-defined cartilage lesion (usually 2–10 cm²), as opposed to a greater number of defects
- Good knee alignment and stable ligaments
- No advanced osteoarthritis or widespread cartilage loss
- Failure of non-surgical treatments (physiotherapy, injections, bracing)
A thorough assessment by an orthopaedic surgeon, including MRI and possibly arthroscopy, is required to determine if ACI is appropriate.
Treating Articular Cartilage Defects
Autologous chondrocyte implantation (ACI) has emerged as an effective treatment for articular cartilage defects of the knee joint, especially in cases where previous surgery has not been performed to repair the defect. The procedure involves harvesting autologous chondrocytes from the patient’s own healthy cartilage, culturing these cells in a laboratory, and then implanting them into the damaged area of the knee. This targeted approach allows for the regeneration of cartilage in areas affected by injury, osteoarthritis, or other causes of joint damage. ACI is typically performed on an outpatient basis, and most patients can expect to gradually return to their normal range of activities within 3 to 6 months, depending on the size and location of the defect. In October 2017, the National Institute for Health and Care Excellence (NICE) approved ACI for use in the treatment of knee cartilage damage, based on strong evidence and research supporting its effectiveness. The procedure is now offered to eligible patients who meet specific criteria, including defect size and location, and is supported by ongoing review and funding to ensure optimal outcomes. For active individuals and sports enthusiasts, ACI provides an important option for restoring joint motion, reducing pain, and returning to a full range of activities.
How Does the ACI Procedure Work?
- Cartilage Harvest: During a keyhole (arthroscopic) procedure, a small sample of healthy cartilage is taken from a non-weight-bearing area of your knee.
- Cell Culturing: The chondrocytes are sent to a laboratory, where they are multiplied over 3–6 weeks.
- Implantation: In a second surgery, the cultured cells are implanted into the cartilage defect, often under a membrane or scaffold to keep them in place.
The new cells grow and integrate with your existing cartilage, gradually restoring the joint surface.
What is Recovery Like After ACI?
Recovery from ACI is a gradual process and requires commitment to rehabilitation:
- Hospital stay: 1–2 days after implantation
- Initial period of non-weight-bearing (crutches) for 6–8 weeks
- Physiotherapy to restore range of motion, strength, and function
- Return to low-impact activities: 3–6 months
- Return to sports: 9–18 months, depending on healing and progress
Time plays a critical role in the healing process, with specific timeframes marking important recovery milestones. Most patients experience significant pain relief and improved knee function, but full recovery can take up to 18 months. Adherence to your rehab plan is crucial for success (Versus Arthritis, 2023).
Benefits and Risks of ACI
Benefits:
- Regenerates your own cartilage for a more natural repair
- Reduces knee pain and swelling
- Improves joint function and quality of life
- May delay or prevent the need for knee replacement in young adults
Risks:
- Infection, bleeding, or blood clots (as with any surgery)
- Graft failure or incomplete healing
- Stiffness or loss of motion
- Need for further surgery in some cases
Success rates are highest in younger, active patients with small, well-defined cartilage defects.
Alternatives and Adjuncts to ACI
- Microfracture surgery (stimulates cartilage repair by creating small holes in bone)
- Osteochondral autograft or allograft transplantation (bone and cartilage plugs)
- Physical therapy and exercise
- Injections (steroid, hyaluronic acid, PRP, or Prolotherapy)
- Weight management and bracing
Your orthopaedic specialist will help you choose the best option based on your age, activity level, and the size and location of your cartilage defect.
Prolotherapy
In recent years, Prolotherapy has built its reputation within the medical community for its clinically proven ability to treat knee pain. Published research has proven its pain-relieving, anti-inflammatory and regenerative benefits.
Prolotherapy involves injecting a natural regenerative solution with tiny needles. This has been shown to stimulate the production of collagen cells, the small cells needed to help with knee pain.
As prolotherapy is helping to treat the root cause of knee pain, it is deemed to be a permanent fix, preventing the symptoms from returning.

Case Studies
Case Study 1: Sarah, a 32-year-old runner, suffered a cartilage injury in her knee after a fall. After failing to improve with physiotherapy and injections, she underwent ACI. With dedicated rehab, she returned to running and reported minimal pain at 18 months post-surgery.
Case Study 2: Mark, a 40-year-old football coach, had persistent knee pain from a cartilage defect. He was not a candidate for ACI due to early arthritis, so he received prolotherapy and a structured exercise program. His pain improved, and he avoided further surgery.
Case Study 3: Linda, a 28-year-old dancer, had a focal cartilage defect treated with ACI. She followed her rehab plan closely and returned to dancing within a year, with no recurrence of knee pain.
FAQs
Who is not suitable for ACI?
ACI is not recommended for patients with advanced osteoarthritis, widespread cartilage loss, or poor knee alignment. It is best for younger, active adults with isolated cartilage defects.
How long does ACI last?
Studies show that ACI can provide pain relief and improved function for 10 years or more in many patients, especially if the rehab plan is followed.
Is ACI better than microfracture?
ACI is generally more effective for larger cartilage defects and in younger patients. Microfracture is less invasive but may not provide durable results for bigger lesions.
Is prolotherapy safe for knee pain?
Prolotherapy is considered safe when performed by a qualified practitioner. It is minimally invasive and has a low risk of complications.
When should I see a specialist?
If you have persistent knee pain, swelling, or locking, or if you have not improved with physiotherapy and conservative care, consult an orthopaedic specialist for assessment.
Conclusion
Autologous chondrocyte implantation is a promising option for young, active patients with knee pain from cartilage defects. With proper patient selection and rehabilitation, ACI can restore function and delay the need for joint replacement. For those not suitable for surgery, regenerative options like prolotherapy offer hope for lasting relief. Always consult a knee specialist to discuss your best treatment options.
Contact ProHealth Clinic Today for Your FREE 15-Minute Discovery Call
Don’t let knee pain control your life any longer. Join the thousands of patients who have found lasting relief through prolotherapy at ProHealth Clinic.
Get in Touch
Phone: +441234380345
Email: info@prohealthclinic.co.uk
Our Clinic Locations
London: 104 Harley Street, Marylebone, W1G 7JD
Manchester: The Hadley Clinic, 64 Bridge Street, M3 3BN
Bedford: The Village Medical Centre, Kingswood Way, MK40 4GH
All clinics offer the same award-winning prolotherapy treatment with convenient appointment times, including evenings and weekends.
Author Bio
Having performed over 10,000 procedures, Mr Oliver Eaton is one of the UK’s leading practitioners in the field of treating knee pain, with patients travelling to see him from across the UK, Europe, and the Middle East.
With over 12 years of clinical experience, Oliver is dedicated to helping patients understand their symptoms associated with knee pain and providing effective treatment options to alleviate them.
He first trained in Prolozone Therapy and Prolotherapy in America with the American Academy of Ozonotherapy and continued on to complete further training with the Royal Society of Medicine, Charing Cross Hospital in London, Keele University’s Anatomy & Surgical Training Centre, and the medical department of Heidelberg University in Germany.
Mr Eaton developed his treatment and examination approach through the process of treating his own chronic symptoms and is committed to making sure his patients experience the same life-changing effects his treatments had on him.
Over the years he has had the privilege of treating many elite-level athletes, including both Olympic and Commonwealth medallists.
Mr Eaton’s expertise has been featured in many national news and media publications, including The Telegraph, The Daily Mail, The Daily Express, Women’s Health Magazine, and The Scotsman.
Linkedin profile: https://www.linkedin.com/in/oliver-eaton-4338225b/
References
- NHS. (2023). Knee Cartilage Surgery
- Versus Arthritis. (2023). Knee Cartilage Surgery
- Arthritis Foundation. (2023). Osteoarthritis
- National Institute for Health and Care Excellence (NICE). (2023). Knee Pain
Disclaimer: This article is for informational purposes only and does not substitute for professional medical advice. Always consult your healthcare provider before making treatment decisions.

